On behalf of NeuroBiogen,

We announce the signing of the Tisolagiline global technology transfer agreement between NeuroBiogen and Scilex Bio Inc., a joint venture between U.S. pharmaceutical company Scilex Holding Inc. and the International Precision Medical Center (IPMC) under the BioOpen Innovation Promotion Association.

 

Please check the distributed press release for details.

-NeuroBiogen Co., Ltd.